Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.

Protein expression of Myristoylated alanine-rich C kinase substrate like-1 (MARCKSL1) has been identified as a prognostic factor in lymph-node negative (LN-) breast cancer patients. We aim to validate MARCKSL1 protein expression as a prognostic marker for distant metastasis-free survival (DMFS) in a...

Full description

Bibliographic Details
Main Authors: Nina Gran Egeland, Marie Austdal, Bianca van Diermen-Hidle, Emma Rewcastle, Einar G Gudlaugsson, Jan P A Baak, Ivar Skaland, Emiel A M Janssen, Kristin Jonsdottir
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0212527

Internet

https://doi.org/10.1371/journal.pone.0212527

Similar Items